|
Tuloxxin
|
100 mg/ml
|
V/DCP/18/0079
|
KRKA, d.d., Novo mesto, Slovēnija
|
QJ01FA94
|
cattle; pigs; sheep
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
solution for injection
|
| International name (active substance): |
Tulathromycin
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
KRKA, d.d., Novo mesto, Slovēnija;TAD Pharma GmbH, Vācija
|
| Date of authorisation/renewal: |
28-Dec-2018
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
DCP
|
| Package leaflet: |
[PDF] 171221LI (10-Apr-2024)
|
| Labelling text: |
[PDF] 171221M (10-Apr-2024)
|
| Summary of product characteristics: |
[DOCX] 171221ZA (10-Apr-2024)
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/DCP/18/0079-01 |
|
1 |
Stikla flakons, 50 ml |
-
|
| V/DCP/18/0079-02 |
|
1 |
Stikla flakons, 100 ml |
-
|
| V/DCP/18/0079-03 |
|
1 |
Stikla flakons, 250 ml |
-
|
|
|
Tolfelab
|
40 mg/ml
|
V/DCP/22/0045
|
Labiana Life Sciences S.A., Spānija
|
QM01AG02
|
cattle; pigs; dogs; cats
|
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/DCP/22/0045-01 |
|
1 |
Stikla flakons, 20 ml |
-
|
| V/DCP/22/0045-02 |
|
1 |
Stikla flakons, 50 ml |
-
|
| V/DCP/22/0045-03 |
|
1 |
Stikla flakons, 100 ml |
-
|
| V/DCP/22/0045-04 |
|
1 |
Stikla flakons, 250 ml |
-
|
|
|
Cepritect
|
250 mg
|
V/DCP/17/0049
|
Norbrook Laboratories (Ireland) Limited, Īrija
|
QJ51DB90
|
dry cows
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/DCP/17/0049-01 |
|
24 |
Injektors, 3 g |
-
|
| V/DCP/17/0049-02 |
|
60 |
Injektors, 3 g |
-
|
| V/DCP/17/0049-03 |
|
120 |
Injektors, 3 g |
-
|
|
|
Milprazon 16 mg/40 mg
|
-
|
V/DCP/14/0073
|
KRKA, d.d., Novo mesto, Slovēnija
|
QP54AB51
|
cats weighing at least 2 kg
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/DCP/14/0073-01 |
|
1 |
Al/OPA/Al/PVH blisteris, 2 tablete |
-
|
| V/DCP/14/0073-02 |
|
1 |
Al/OPA/Al/PVH blisteris, 4 tablete |
-
|
| V/DCP/14/0073-03 |
|
12 |
Al/OPA/Al/PVH blisteris, 4 tablete |
-
|
|
|
Bupredine Multidose vet
|
0.3 mg/ml
|
V/DCP/15/0048
|
Le Vet Beheer B.V., Nīderlande
|
QN02AE01
|
horses; dogs; cats
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
solution for injection
|
| International name (active substance): |
Buprenorphine hydrochloride
|
| Distribution category: |
To be used only by veterinary surgeon
|
| Manufacturer(s) responsible for batch release |
Produlab Pharma b.v., Nīderlande
|
| Date of authorisation/renewal: |
20-Dec-2021
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
DCP
|
| Package leaflet: |
[DOCX] 20122021LI (23-Dec-2021)
|
| Labelling text: |
[DOCX] 20122021M (23-Dec-2021)
|
| Summary of product characteristics: |
[DOCX] 20122021ZA (23-Dec-2021)
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/DCP/15/0048-01 |
0,3 mg/ml |
1 |
Stikla flakons, 5 ml |
-
|
| V/DCP/15/0048-02 |
0,3 mg/ml |
1 |
Stikla flakons, 10 ml |
-
|
| V/DCP/15/0048-03 |
0,3 mg/ml |
1 |
Stikla flakons, 20 ml |
-
|
| V/DCP/15/0048-04 |
0,3 mg/ml |
1 |
Stikla flakons, 50 ml |
-
|
| V/DCP/15/0048-05 |
0,3 mg/ml |
1 |
Stikla flakons, 100 ml |
-
|
|
|
Ultrapen LA
|
300 mg/ml
|
V/NRP/98/0939
|
Norbrook Laboratories (Ireland) Limited, Īrija
|
QJ01CE09
|
cattle; pigs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
suspension for injection
|
| International name (active substance): |
Procaine benzylpenicillin
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Norbrook Laboratories Limited, Lielbritānija;Norbrook Manufacturing Limited, Īrija
|
| Date of authorisation/renewal: |
09-Feb-2009
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
NRP
|
| Package leaflet: |
[DOCX] 15052024_LI (14-May-2024)
|
| Labelling text: |
[DOCX] 15052024_M (14-May-2024)
|
| Summary of product characteristics: |
[DOCX] 15052024_ZA (14-May-2024)
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/NRP/98/0939-01 |
300 mg/ml |
1 |
Stikla flakons, 50 ml |
-
|
| V/NRP/98/0939-02 |
300 mg/ml |
1 |
Stikla flakons, 100 ml |
-
|
|
|
Be-Complex
|
-
|
V/NRP/94/0280
|
Bela-pharm GmbH&Co.KG, Vācija
|
QA11EX
|
cattle; pigs; horses; dogs; cats; minks; foxes
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
solution for injection
|
| International name (active substance): |
Thiamine hydrochloride, Riboflavine sodium phosphate, Pyridoxine hydrochloride, Nicotinamide, Calcium pantothenate
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Bela-pharm GmbH&Co.KG, Vācija
|
| Date of authorisation/renewal: |
07-Oct-2011
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
NRP
|
| Package leaflet: |
[PDF] Skat_sadaļā_Zāļu_apraksts (27-Aug-2024)
|
| Labelling text: |
[PDF] Skat_sadaļā_Zāļu_apraksts (27-Aug-2024)
|
| Summary of product characteristics: |
[DOCX] Zāļu_informācija_ZA_M_LI (27-Aug-2024)
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/NRP/94/0280-01 |
|
1 |
Stikla flakons, 50 ml |
-
|
| V/NRP/94/0280-02 |
|
6 |
Stikla flakons, 50 ml |
-
|
| V/NRP/94/0280-03 |
|
12 |
Stikla flakons, 50 ml |
-
|
| V/NRP/94/0280-08 |
|
1 |
Stikla flakons, 100 ml |
-
|
| V/NRP/94/0280-09 |
|
6 |
Stikla flakons, 100 ml |
-
|
| V/NRP/94/0280-10 |
|
12 |
Stikla flakons, 100 ml |
-
|
| V/NRP/94/0280-15 |
|
1 |
Stikla flakons, 250 ml |
-
|
| V/NRP/94/0280-16 |
|
6 |
Stikla (tumša) flakons, 250 ml |
-
|
| V/NRP/94/0280-17 |
|
12 |
Stikla flakons, 250 ml |
-
|
|
|
Nobilis Reo+IB+G+ND
|
-
|
V/NRP/95/0179
|
Intervet International B.V., Nīderlande
|
QI01AA16
|
chickens
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
emulsion for injection
|
| International name (active substance): |
Inactivated Newcastle disease virus, strain Clone 30,Inactivated reovirus strain 1733 and 2408,Inactivated avian infectious bronchitis virus, strain M41 ,Inactivated infectious bursal disease virus, strain D78
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Intervet International B.V., Nīderlande
|
| Date of authorisation/renewal: |
15-Oct-2010
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
NRP
|
| Package leaflet: |
[PDF] Skat_sadaļā_Zāļu_apraksts (19-Oct-2023)
|
| Labelling text: |
[PDF] Skat_sadaļā_Zāļu_apraksts (19-Oct-2023)
|
| Summary of product characteristics: |
[DOCX] Zāļu_informācija_ZA_M_LI (07-Mar-2024)
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/NRP/95/0179-01 |
|
1 |
Stikla flakons, 1000 deva |
-
|
| V/NRP/95/0179-02 |
|
1 |
PET pudele, 1000 deva |
-
|
|
|
Benestermycin
|
-
|
V/NRP/96/0294
|
Boehringer Ingelheim Vetmedica GmbH, Vācija
|
QJ51RC25
|
cattle
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
intramammary suspension
|
| International name (active substance): |
Penethamate hydroiodide, Benethamine penicillin, Framycetin sulphate
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Haupt Pharma Latina S.R.L., Itālija;Lohmann Pharma Herstellung GmbH, Vācija
|
| Date of authorisation/renewal: |
15-Jul-2008
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
NRP
|
| Package leaflet: |
[PDF] Skat_sadaļā_Zāļu_apraksts (10-May-2024)
|
| Labelling text: |
[PDF] Skat_sadaļā_Zāļu_apraksts (10-May-2024)
|
| Summary of product characteristics: |
[DOCX] Zāļu_informācija_ZA_M_LI (10-May-2024)
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/NRP/96/0294-01 |
|
20 |
Injektors, 1 deva |
-
|
|
|
Cobactan LC
|
75 mg
|
V/NRP/01/1288
|
Intervet International BV, Nīderlande
|
QJ51DE90
|
cattle (lactating cows)
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
intramammary ointment
|
| International name (active substance): |
Cefquinome (as cefquinome sulfate)
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Hoechst Roussel Vet, Francija;Intervet International BV, Nīderlande;INTERVET INTERNATIONAL GMBH, Vācija
|
| Date of authorisation/renewal: |
03-Aug-2010
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
NRP
|
| Package leaflet: |
[PDF] Skat_sadaļā_Zāļu_apraksts (10-May-2024)
|
| Labelling text: |
[PDF] Skat_sadaļā_Zāļu_apraksts (10-May-2024)
|
| Summary of product characteristics: |
[DOCX] Zāļu_informācija_ZA_M_LI (10-May-2024)
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/NRP/01/1288-01 |
75 mg/deva |
3 |
Injektors, 1 deva |
-
|
| V/NRP/01/1288-02 |
75 mg/deva |
15 |
Injektors, 1 deva |
-
|
| V/NRP/01/1288-03 |
75 mg/deva |
20 |
Injektors, 1 deva |
-
|
| V/NRP/01/1288-04 |
75 mg/deva |
24 |
Injektors, 1 deva |
-
|
|
|
Bovilis IBR marker live
|
-
|
V/NRP/02/1525
|
Intervet International B.V., Nīderlande
|
QI02AD01
|
cattle
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/NRP/02/1525-05 |
|
1 |
Stikla flakons, 5 deva |
-
|
| V/NRP/02/1525-06 |
|
10 |
Stikla flakons, 10 deva |
-
|
| V/NRP/02/1525-07 |
|
10 |
Stikla flakons, 5 deva |
-
|
| V/NRP/02/1525-08 |
|
1 |
Stikla flakons, 10 deva |
-
|
| V/NRP/02/1525-09 |
|
1 |
Stikla flakons, 25 deva |
-
|
| V/NRP/02/1525-10 |
|
10 |
Stikla flakons, 25 deva |
-
|
| V/NRP/02/1525-11 |
|
1 |
Stikla flakons (šķīdinātājs stikla flakonā), 50 deva |
-
|
| V/NRP/02/1525-12 |
|
10 |
Stikla flakons (šķīdinātājs stikla flakonā), 50 deva |
-
|
| V/NRP/02/1525-13 |
|
1 |
Stikla flakons, 100 deva |
-
|
| V/NRP/02/1525-14 |
|
10 |
Stikla flakons, 100 deva |
-
|
| V/NRP/02/1525-15 |
|
1 |
Stikla flakons (šķīdinātājs PET flakonā), 50 deva |
-
|
| V/NRP/02/1525-16 |
|
10 |
Stikla flakons (šķīdinātājs PET flakonā), 50 deva |
-
|
|
|
Floron oral solution 100 mg/ml
|
-
|
V/NRP/01/1416
|
KRKA, d.d., Novo mesto, Slovēnija
|
QJ01BA90
|
pigs; chickens
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/NRP/01/1416-01 |
100 mg/ml |
1 |
Pudelīte, 100 ml |
-
|
| V/NRP/01/1416-02 |
100 mg/ml |
1 |
Flakons, 1000 ml |
-
|
|
|
Nobilis Reo inac
|
-
|
V/NRP/03/1558
|
Intervet International B.V., Nīderlande
|
QI01AA04
|
chickens
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/NRP/03/1558-01 |
|
1 |
Stikla flakons, 1000 deva |
-
|
| V/NRP/03/1558-03 |
|
1 |
PET flakons, 1000 deva |
-
|
|
|
Bimectin
|
10 mg/ml
|
V/NRP/07/1703
|
Bimeda Animal Health Limited, Īrija
|
QP54AA01
|
cattle; pigs; sheep
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/NRP/07/1703-01 |
10 mg/ml |
1 |
Polietilēna pudele, 50 ml |
-
|
| V/NRP/07/1703-02 |
10 mg/ml |
1 |
Polietilēna pudele, 250 ml |
-
|
| V/NRP/07/1703-03 |
10 mg/ml |
1 |
Polietilēna pudele, 500 ml |
-
|
|
|
Marbocyl P 80mg
|
-
|
V/NRP/08/1577
|
Vetoquinol S.A., Francija
|
QJ01MA93
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
tablets
|
| International name (active substance): |
Marbofloxacin
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Vetoquinol S.A., Francija
|
| Date of authorisation/renewal: |
18-Aug-2008
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
NRP
|
| Package leaflet: |
[PDF] 090710LI (19-Jul-2010)
|
| Labelling text: |
[DOC] 090710_M (19-Jul-2010)
|
| Summary of product characteristics: |
[PDF] 090710ZA (19-Jul-2010)
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/NRP/08/1577-01 |
80 mg |
1 |
Alumīnija blisteris, 6 tablete |
-
|
| V/NRP/08/1577-02 |
80 mg |
2 |
Alumīnija blisteris, 6 tablete |
-
|
| V/NRP/08/1577-03 |
80 mg |
3 |
Alumīnija blisteris, 6 tablete |
-
|
| V/NRP/08/1577-04 |
80 mg |
4 |
Alumīnija blisteris, 6 tablete |
-
|
| V/NRP/08/1577-05 |
80 mg |
5 |
Alumīnija blisteris, 6 tablete |
-
|
| V/NRP/08/1577-06 |
80 mg |
8 |
Alumīnija blisteris, 6 tablete |
-
|
| V/NRP/08/1577-07 |
80 mg |
12 |
Alumīnija blisteris, 6 tablete |
-
|
| V/NRP/08/1577-08 |
80 mg |
16 |
Alumīnija blisteris, 6 tablete |
-
|
| V/NRP/08/1577-09 |
80 mg |
20 |
Alumīnija blisteris, 6 tablete |
-
|
| V/NRP/08/1577-10 |
80 mg |
40 |
Alumīnija blisteris, 6 tablete |
-
|
| V/NRP/08/1577-11 |
80 mg |
80 |
Alumīnija blisteris, 6 tablete |
-
|
|
|
Porcilis Ery
|
-
|
V/NRP/96/0377
|
Intervet International B.V., Nīderlande
|
QI09AB03
|
pigs
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/NRP/96/0377-01 |
|
1 |
Pudelīte, 10 deva |
-
|
| V/NRP/96/0377-02 |
|
1 |
Pudelīte, 25 deva |
-
|
| V/NRP/96/0377-03 |
|
1 |
Pudelīte, 50 deva |
-
|
| V/NRP/96/0377-04 |
|
1 |
Pudelīte, 125 deva |
-
|
|
|
Nafpenzal DC
|
-
|
V/NRP/93/0034
|
Intervet International B.V., Nīderlande
|
QJ51RC23
|
cattle
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/NRP/93/0034-01 |
|
4 |
Injektors, 1 deva |
-
|
| V/NRP/93/0034-02 |
|
20 |
Injektors, 1 deva |
-
|
|
|
BioEquin FT
|
-
|
V/NRP/20/0021
|
Bioveta, ,a.s., Čehija
|
QI05AL01
|
horses
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
suspension for injection
|
| International name (active substance): |
Inactivated equine influenza virus, strain A/Equi 2/Brno 08 (American type) H3N8, Inactivated equine influenza virus, strain A/Equi 2/ Morava 95 (European type) H3N8, Tetanus toxoid
|
| Distribution category: |
To be used only by veterinary surgeon
|
| Manufacturer(s) responsible for batch release |
Bioveta, a.s., Čehija
|
| Date of authorisation/renewal: |
28-Jan-2022
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
NRP
|
| Package leaflet: |
[DOCX] 23102020LI (23-Oct-2020)
|
| Labelling text: |
[DOCX] 23102020M (23-Oct-2020)
|
| Summary of product characteristics: |
[DOCX] 23102020ZA (23-Oct-2020)
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/NRP/20/0021-01 |
|
2 |
Stikla flakons, 1 deva |
-
|
| V/NRP/20/0021-02 |
|
5 |
Stikla flakons, 1 deva |
-
|
| V/NRP/20/0021-03 |
|
10 |
Stikla flakons, 1 deva |
-
|
| V/NRP/20/0021-04 |
|
1 |
Stikla flakons, 5 deva |
-
|
| V/NRP/20/0021-05 |
|
10 |
Stikla flakons, 5 deva |
-
|
|
|
MELCAM 1.5 mg/ml
|
1.5 mg/ml
|
V/NRP/22/0009
|
Bioveta, a.s., Čehija
|
QM01AC06
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
suspension for oral use
|
| International name (active substance): |
Meloxicam
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Bioveta, a.s., Čehija
|
| Date of authorisation/renewal: |
23-Feb-2022
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
NRP
|
| Package leaflet: |
[DOCX] 260722LI (26-Jul-2022)
|
| Labelling text: |
[DOCX] 260722M (26-Jul-2022)
|
| Summary of product characteristics: |
[DOCX] 260272ZA (26-Jul-2022)
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/NRP/22/0009-01 |
|
1 |
Polietilēna pudele, 10 ml |
-
|
| V/NRP/22/0009-02 |
|
1 |
Polietilēna pudele, 30 ml |
-
|
| V/NRP/22/0009-03 |
|
1 |
Polietilēna pudele, 100 ml |
-
|
|
|
Intramar LC
|
-
|
V/NRP/20/0064
|
Bioveta, a.s., Čehija
|
QJ51RV01
|
cattle
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
intramammary suspension
|
| International name (active substance): |
Amoxicillin trihydrate, Potassium clavulanate, Prednisolone
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Bioveta, a.s., Čehija
|
| Date of authorisation/renewal: |
28-Jan-2022
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
NRP
|
| Package leaflet: |
[DOCX] 26012021LI (26-Jan-2021)
|
| Labelling text: |
[DOCX] 26012021M (26-Jan-2021)
|
| Summary of product characteristics: |
[DOCX] 26012021ZA (26-Jan-2021)
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/NRP/20/0064-01 |
|
24 |
Injektors, 4 g |
-
|
|